MMP2 and diabetic retinopathy: The MMP2-AS1 regulatory mechanism provides a novel therapeutic target, as interventions could potentially modulate this lncRNA-microRNA-mRNA network to control MMP2-mediated vascular damage in diabetic retinopathy.